{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:43:25Z","timestamp":1792035805216,"version":"4.4.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP2009851"],"award-info":[{"award-number":["APP2009851"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024053","name":"Sydney Local Health District","doi-asserted-by":"publisher","award":["NCT05387148"],"award-info":[{"award-number":["NCT05387148"]}],"id":[{"id":"10.13039\/501100024053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.conctc.2024.101341","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T17:35:19Z","timestamp":1723570519000},"page":"101341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial"],"prefix":"10.1016","volume":"41","author":[{"given":"Tristan P.","family":"Hurzeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Logge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6697-2158","authenticated-orcid":false,"given":"Joshua","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena M.","family":"DeMayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Suraev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9307-7159","authenticated-orcid":false,"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0868-9928","authenticated-orcid":false,"given":"Kirsten C.","family":"Morley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.conctc.2024.101341_bib1","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1080\/14656566.2021.1892641","article-title":"New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies","volume":"22","author":"Morley","year":"2021","journal-title":"Expet Opin. Pharmacother."},{"issue":"9","key":"10.1016\/j.conctc.2024.101341_bib2","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/epi.13852","article-title":"Interactions between cannabidiol and commonly used antiepileptic drugs","volume":"58","author":"Gaston","year":"2017","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib3","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"14","key":"10.1016\/j.conctc.2024.101341_bib4","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S2045796018000239","article-title":"Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview","volume":"27","author":"Mandolini","year":"2018","journal-title":"Epidemiol. Psychiatr. Sci."},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1196\/annals.1316.064","article-title":"Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors","volume":"1025","author":"Hungund","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.conctc.2024.101341_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107360","article-title":"Cannabidiol in the context of substance use disorder treatment: a systematic review","volume":"132","author":"Paulus","year":"2022","journal-title":"Addict. Behav."},{"issue":"S2","key":"10.1016\/j.conctc.2024.101341_bib8","first-page":"6","article-title":"The endocannabinoid system and its modulation by cannabidiol (CBD)","volume":"25","author":"Corroon","year":"2019","journal-title":"Alternative Ther. Health Med."},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.conctc.2024.101341_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pbb.2011.01.007","article-title":"Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists","volume":"98","author":"Scopinho","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.conctc.2024.101341_bib12","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14130","article-title":"Cannabidiol for treatment-resistant anxiety disorders in young people: an open-label trial","volume":"83","author":"Berger","year":"2022","journal-title":"J. Clin. Psychiatr."},{"issue":"11","key":"10.1016\/j.conctc.2024.101341_bib13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2018.2309","article-title":"Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial","volume":"75","author":"Bhattacharyya","year":"2018","journal-title":"JAMA Psychiatr."},{"issue":"11","key":"10.1016\/j.conctc.2024.101341_bib14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","article-title":"Neural basis of \u0394-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition","volume":"64","author":"Borgwardt","year":"2008","journal-title":"Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by \u03949-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.conctc.2024.101341_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93760","article-title":"A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study","volume":"2","author":"Jadoon","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-019-0534-2","article-title":"Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis","volume":"9","author":"Wilson","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.conctc.2024.101341_bib18","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.conctc.2024.101341_bib19","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol \u2013 recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"47","key":"10.1016\/j.conctc.2024.101341_bib20","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.conctc.2024.101341_bib21","first-page":"2036","article-title":"Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle","volume":"43","author":"Gonzalez-Cuevas","year":"2018"},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/adb.12495","article-title":"Cannabidiol reduces ethanol consumption, motivation and relapse in mice","volume":"23","author":"Viudez-Martinez","year":"2018","journal-title":"Addiction Biol."},{"issue":"9","key":"10.1016\/j.conctc.2024.101341_bib23","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addict. Behav."},{"issue":"11","key":"10.1016\/j.conctc.2024.101341_bib24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/adb.12366","article-title":"Cannabidiol disrupts the reconsolidation of contextual drug\u2010associated memories in Wistar rats","volume":"22","author":"de Carvalho","year":"2017","journal-title":"Addiction Biol."},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.conctc.2024.101341_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamapsychiatry.2022.1240","article-title":"Association of drug cues and craving with drug use and relapse: a systematic review and meta-analysis","volume":"79","author":"Vafaie","year":"2022","journal-title":"JAMA Psychiatr."},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/09595230601036960","article-title":"Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications","volume":"26","author":"Sinha","year":"2007","journal-title":"Drug Alcohol Rev."},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s42238-024-00224-0","article-title":"Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic","volume":"6","author":"Hurzeler","year":"2023","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.conctc.2024.101341_bib30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/dta.3419","article-title":"How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials","volume":"15","author":"McCartney","year":"2023","journal-title":"Drug Test. Anal."},{"issue":"Suppl 20","key":"10.1016\/j.conctc.2024.101341_bib32","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatr."},{"issue":"6","key":"10.1016\/j.conctc.2024.101341_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/alcalc\/agu062","article-title":"Baclofen for the treatment of alcohol dependence and possible role of comorbid anxiety","volume":"49","author":"Morley","year":"2014","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.conctc.2024.101341_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1940-0640-8-19","article-title":"Integrated care for comorbid alcohol dependence and anxiety and\/or depressive disorder: study protocol for an assessor-blind, randomized controlled trial","volume":"8","author":"Morley","year":"2013","journal-title":"Addiction Sci. Clin. Pract."},{"issue":"2","key":"10.1016\/j.conctc.2024.101341_bib35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cct.2013.08.002","article-title":"The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial","volume":"36","author":"Morley","year":"2013","journal-title":"Contemp. Clin. Trials"},{"issue":"10","key":"10.1016\/j.conctc.2024.101341_bib36","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1360-0443.2006.01555.x","article-title":"Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial","volume":"101","author":"Morley","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.conctc.2024.101341_bib37","first-page":"393","article-title":"Reliability of a timeline followback method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"Sobell","year":"1988","journal-title":"BJA (Br. J. Addict.)"},{"key":"10.1016\/j.conctc.2024.101341_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1037\/0021-843X.91.3.199","article-title":"Alcohol dependence syndrome: measurement and validation","volume":"91","author":"Skinner","year":"1982","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.conctc.2024.101341_bib39","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","article-title":"Psychometric properties of the Penn alcohol craving scale","volume":"28","author":"Flannery","year":"1999","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.conctc.2024.101341_bib40","volume":"4","author":"Miller","year":"1995"},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib41","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1530-0277.1994.tb00050.x","article-title":"Anxiety and drinking behavior: moderating effects of tension-reduction alcohol outcome expectancies","volume":"18","author":"Kushner","year":"1994","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-U","article-title":"The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories","volume":"33","author":"Lovibond","year":"1995","journal-title":"Behav. Res. Ther."},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med."},{"key":"10.1016\/j.conctc.2024.101341_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.15288\/jsa.1994.55.141","article-title":"The alcohol abstinence self-efficacy scale","volume":"55","author":"DiClemente","year":"1994","journal-title":"J. Stud. Alcohol"},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1530-0277.1995.tb01475.x","article-title":"The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior","volume":"19","author":"Anton","year":"1995","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.conctc.2024.101341_bib46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1037\/0022-3514.67.2.319","article-title":"Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS\/BAS scales","volume":"67","author":"Carver","year":"1994","journal-title":"J. Pers. Soc. Psychol."},{"issue":"6","key":"10.1016\/j.conctc.2024.101341_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0191-8869(94)90048-5","article-title":"Why do people worry?","volume":"17","author":"Freeston","year":"1994","journal-title":"Pers. Indiv. Differ."},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0191-8869(00)00064-7","article-title":"The five factor model and impulsivity: using a structural model of personality to understand impulsivity","volume":"30","author":"Whiteside","year":"2001","journal-title":"Pers. Indiv. Differ."},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib49","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1530-0277.1995.tb01554.x","article-title":"Development and initial validation of a measure of drinking urges in abstinent alcoholics","volume":"19","author":"Bohn","year":"1995","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"6","key":"10.1016\/j.conctc.2024.101341_bib50","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: the PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J. Pers. Soc. Psychol."},{"issue":"2","key":"10.1016\/j.conctc.2024.101341_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00434408","article-title":"The Leeds sleep evaluation questionnaire in psychopharmacological investigations\u2014a review","volume":"71","author":"Parrott","year":"1980","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.conctc.2024.101341_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5665\/sleep.1642","article-title":"The consensus sleep diary: standardizing prospective sleep self-monitoring","volume":"35","author":"Carney","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.conctc.2024.101341_bib53","series-title":"Sema3: Smartphone Ecological Momentary Assessment, Version 3","author":"Koval","year":"2019"},{"key":"10.1016\/j.conctc.2024.101341_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/0096-3445.124.2.207","article-title":"Costs of a predictable switch between simple cognitive tasks","volume":"124","author":"Rogers","year":"1995","journal-title":"J. Exp. Psychol. Gen."},{"issue":"6","key":"10.1016\/j.conctc.2024.101341_bib55","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"J. Exp. Psychol."},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/nimg.1996.0247","article-title":"A parametric study of prefrontal cortex involvement in human working memory","volume":"5","author":"Braver","year":"1997","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib57","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1162\/jocn.1997.9.4.462","article-title":"Verbal working memory load affects regional brain activation as measured by PET","volume":"9","author":"Jonides","year":"1997","journal-title":"J. Cognit. Neurosci."},{"issue":"2","key":"10.1016\/j.conctc.2024.101341_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1037\/1076-898X.8.2.75","article-title":"Evaluation of a behavioral measure of risk taking: the Balloon analogue risk task (BART)","volume":"8","author":"Lejuez","year":"2002","journal-title":"J. Exp. Psychol. Appl."},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib59","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1037\/a0014983","article-title":"Affective and deliberative processes in risky choice: age differences in risk taking in the Columbia Card Task","volume":"35","author":"Figner","year":"2009","journal-title":"J. Exp. Psychol. Learn. Mem. Cognit."},{"key":"10.1016\/j.conctc.2024.101341_bib60","volume":"4","author":"Reitan","year":"1985"},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mrm.26233","article-title":"HERMES: Hadamard encoding and reconstruction of MEGA-edited spectroscopy","volume":"76","author":"Chan","year":"2016","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.conctc.2024.101341_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104889","article-title":"GSH and GABA decreases in IDH1-mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo","volume":"141","author":"Gong","year":"2020","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4227","article-title":"Simultaneous edited MRS of GABA, glutathione, and ethanol","volume":"33","author":"Saleh","year":"2020","journal-title":"NMR Biomed."},{"issue":"37","key":"10.1016\/j.conctc.2024.101341_bib64","doi-asserted-by":"crossref","first-page":"15037","DOI":"10.1073\/pnas.1010654108","article-title":"Addiction: beyond dopamine reward circuitry","volume":"108","author":"Volkow","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib65","first-page":"120","article-title":"Compensation of susceptibility-induced BOLD sensitivity losses in echo-planar fMRI imaging","volume":"15","author":"Deichmann","year":"2002"},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib66","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00213-004-1828-4","article-title":"Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics","volume":"175","author":"Gr\u00fcsser","year":"2004","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.conctc.2024.101341_bib67","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3758\/s13428-013-0379-1","article-title":"The Nencki Affective Picture System (NAPS): introduction to a novel, standardized, wide-range, high-quality, realistic picture database","volume":"46","author":"Marchewka","year":"2014","journal-title":"Behav. Res. Methods"},{"issue":"2","key":"10.1016\/j.conctc.2024.101341_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2722","article-title":"Baclofen modulates cardiovascular responses to appetitive cues in treatment-seeking alcohol use disorder individuals","volume":"35","author":"Logge","year":"2020","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.conctc.2024.101341_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108827","article-title":"Osprey: open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data","volume":"343","author":"Oeltzschner","year":"2020","journal-title":"J. Neurosci. Methods"},{"issue":"6","key":"10.1016\/j.conctc.2024.101341_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3914","article-title":"Errors in (1) H-MRS estimates of brain metabolite concentrations caused by failing to take into account tissue-specific signal relaxation","volume":"31","author":"Gasparovic","year":"2018","journal-title":"NMR Biomed."},{"issue":"6","key":"10.1016\/j.conctc.2024.101341_bib71","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/mrm.20901","article-title":"Use of tissue water as a concentration reference for proton spectroscopic imaging","volume":"55","author":"Gasparovic","year":"2006","journal-title":"Magn. Reson. Med."},{"issue":"5","key":"10.1016\/j.conctc.2024.101341_bib72","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jmri.24903","article-title":"Tissue correction for GABA-edited MRS: considerations of voxel composition, tissue segmentation, and tissue relaxations","volume":"42","author":"Harris","year":"2015","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.conctc.2024.101341_bib73","article-title":"CrossCarry: an R package for the analysis of data from a crossover design with GEE","author":"Cruz","year":"2023","journal-title":"arXiv preprint arXiv:.02440"},{"key":"10.1016\/j.conctc.2024.101341_bib74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib75","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/acer.12977","article-title":"Associations between recent heavy drinking and dorsal anterior cingulate N\u2010acetylaspartate and glutamate concentrations in non\u2010treatment\u2010seeking individuals with alcohol dependence","volume":"40","author":"Prisciandaro","year":"2016","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.conctc.2024.101341_bib76","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41596-020-0327-3","article-title":"Analysis of task-based functional MRI data preprocessed with fMRIPrep","volume":"15","author":"Esteban","year":"2020","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41592-018-0235-4","article-title":"fMRIPrep: a robust preprocessing pipeline for functional MRI","volume":"16","author":"Esteban","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.conctc.2024.101341_bib78","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuroimage.2017.03.020","article-title":"Benchmarking of participant-level confound regression strategies for the control of motion artifact in studies of functional connectivity","volume":"154","author":"Ciric","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.conctc.2024.101341_bib79","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuroimage.2012.08.052","article-title":"An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data","volume":"64","author":"Satterthwaite","year":"2013","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib80","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrn789","article-title":"Mapping context and content: the BrainMap model","volume":"3","author":"Fox","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.conctc.2024.101341_bib81","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/acer.14167","article-title":"The use of functional magnetic resonance imaging to test pharmacotherapies for alcohol use disorder: a systematic review","volume":"43","author":"Grodin","year":"2019","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.conctc.2024.101341_bib82","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2021.06.031","article-title":"Neurobiological correlates of cue-reactivity in alcohol-use disorders: a voxel-wise meta-analysis of fMRI studies","volume":"128","author":"Zeng","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.conctc.2024.101341_bib83","first-page":"500","article-title":"Neural signatures of human fear conditioning: an updated and extended meta-analysis of fMRI studies","volume":"21","author":"Fullana","year":"2016"},{"key":"10.1016\/j.conctc.2024.101341_bib84","series-title":"8th International Conference on Functional Mapping of the Human Brain","article-title":"Region of interest analysis using an SPM toolbox","author":"Brett","year":"2002"},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13069","article-title":"Test\u2013retest reliability of neural alcohol cue\u2010reactivity: is there light at the end of the magnetic resonance imaging tube?","volume":"27","author":"Bach","year":"2022","journal-title":"Addiction Biol."},{"key":"10.1016\/j.conctc.2024.101341_bib86","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/947529","article-title":"Acute effects of alcohol on the human brain: a resting-state FMRI study","volume":"2015","author":"Zheng","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.conctc.2024.101341_bib87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/brain.2012.0073","article-title":"Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks","volume":"2","author":"Whitfield-Gabrieli","year":"2012","journal-title":"Brain Connect."},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib88","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false Discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Roy. Stat. Soc. B"},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1037\/0893-164X.8.1.29","article-title":"Effects of alcohol administration on psychophysiological and subjective-emotional responses to aversive stimulation in anxiety-sensitive women","volume":"8","author":"Stewart","year":"1994","journal-title":"Psychol. Addict. Behav."},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/acer.12270","article-title":"Characteristics of heart rate variability in alcohol\u2010dependent subjects and nondependent chronic alcohol users","volume":"38","author":"Karpyak","year":"2014","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"6","key":"10.1016\/j.conctc.2024.101341_bib91","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1530-0277.2011.01442.x","article-title":"Changes in heart rate variability associated with acute alcohol consumption: current knowledge and implications for practice and research","volume":"35","author":"Romanowicz","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.conctc.2024.101341_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","article-title":"Addiction and the brain antireward system","volume":"59","author":"Koob","year":"2008","journal-title":"Annu. Rev. Psychol."},{"issue":"7","key":"10.1016\/j.conctc.2024.101341_bib93","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00213-021-05823-w","article-title":"Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study","volume":"238","author":"Spinella","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis and cannabinoid research"},{"issue":"1","key":"10.1016\/j.conctc.2024.101341_bib95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cts.13425","article-title":"The safety and efficacy of low oral doses of cannabidiol: an evaluation of the evidence","volume":"16","author":"Arnold","year":"2023","journal-title":"Clinical and Translational Science"}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T17:51:41Z","timestamp":1726681901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865424000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":95,"alternative-id":["S2451865424000887"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101341","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101341"}}